Clinical trials
Multiple Sclerosis (MS) - Relapsing-remitting clinical trials
Below are recruiting multiple sclerosis (ms) - relapsing-remitting clinical trials, each written for real people, not researchers. We’re tracking 233 recruiting studies, each written for real people, not researchers, below.
Recruiting studies
- NCT07462338Enrolling by invitation
Walking test reliability in multiple sclerosis patients
This study checks how reliable a simple walking test (Timed Up and Go) is for people with multiple sclerosis, especially when they do another task at the same time. It aims to improve how doctors measure walking ability.
Gaziantep, GaziantepAges 18–65 - NCT06735053Recruiting
Virtual reality physiotherapy for multiple sclerosis patients
This trial tests whether virtual reality exercises can help people with advanced multiple sclerosis improve their movement and walking. You may qualify if you need two walking aids and your MS has been stable for the last six months.
Móstoles, MadridAges 18–70 - NCT06764563Recruiting
Mediterranean diet study for multiple sclerosis quality of life
This trial tests whether following a Mediterranean diet can improve quality of life for people with multiple sclerosis (MS). It aims to find a dietary approach that may help manage symptoms and improve well-being.
Tel Aviv, IsraelAges 18–70 - NCT05395624RecruitingPhase 1/Phase 2
Safety imaging study of a PET tracer in ALS, Alzheimer, MS, Parkinson
This early-phase study tests the safety of a radioactive tracer (“18F-OP-801”) and how the tracer moves through the body (biodistribution) in people with ALS, Alzheimer’s disease, multiple sclerosis, Parkinson’s disease, and in healthy volunteers. It also measures how the body processes the tracer (“pharmacokinetics”) to support future studies.
San Francisco, CaliforniaAges 18–80 - NCT07106255Enrolling by invitation
Task training for multiple sclerosis patients
This trial tests a task-oriented training program to help improve hand and finger movement in people with multiple sclerosis.
Granada, GranadaAges 18 years+ - NCT06968676Recruiting
Mixed reality for arm rehab in multiple sclerosis
This trial tests if mixed reality (a blend of real and virtual environments) can improve arm and hand function in people with multiple sclerosis. It may help you move your arm better and with less stiffness.
Leganés, MadridAges 18 years+ - NCT06955962Enrolling by invitation
Mandala art therapy for multiple sclerosis symptoms and quality of life
This trial tests whether creating mandala art can help improve symptoms and quality of life for people with multiple sclerosis. You would participate in art sessions while continuing your regular MS care.
TrabzonAges 18–65 - NCT06809192Recruiting
Cognitive behavioral therapy for multiple sclerosis fatigue
This study will test different parts of cognitive behavioral therapy to see which ones help with fatigue in people with multiple sclerosis. You will participate in sessions that may involve changing thoughts about fatigue, scheduling activities, or addressing related emotions like depression or anxiety.
Seattle, WashingtonAges 18 years+ - NCT06782490RecruitingPhase 2
Testing a new drug for MS muscle stiffness
This study tests an investigational drug (BMS-986368) to see if it helps reduce muscle stiffness and spasms caused by multiple sclerosis. It may be an option if you have had spasticity for at least 6 months and are not currently using other treatments that cannot be paused.
Birmingham, AlabamaAges 18–70 - NCT06261528Enrolling by invitationPhase 1
Light therapy for sleepiness in progressive MS
This trial tests whether a special light therapy can help people with progressive multiple sclerosis who feel sleepy during the day. It aims to improve energy, mood, and sleep patterns.
Dallas, TexasAges 18 years+ - NCT04625049Enrolling by invitation
PET and MRI study in people with multiple sclerosis
This trial studies how certain brain immune activity relates to multiple sclerosis (MS) lesion growth and progression using PET and MRI scans. Your participation may help researchers understand disease changes over time and improve how MS is tracked.
Turku, Southwest FinlandAges 30–80 - NCT02784210RecruitingPhase 2
Steroid treatment to reduce inflammation in active MS lesions
This Phase 2 study tests whether corticosteroid medicine can reduce inflammation at the edge of active multiple sclerosis (MS) plaques seen on MRI. It may help calm “hot” areas in the brain where MS activity is happening.
Bethesda, MarylandAges 18–120 - NCT07771868Recruiting
High-intensity interval training for walking in multiple sclerosis
This study tests whether high-intensity interval training (short bursts of intense exercise on a bike) can improve walking and daily function in people with multiple sclerosis across different disability levels. It might help you stay mobile and active.
HatayAges 18–65 - NCT07738120Recruiting
Virtual reality and exercise for multiple sclerosis
This study tests whether using virtual reality along with exercise can help people with multiple sclerosis. It aims to improve physical function and well-being.
PontevedraAges 18 years+ - NCT07424027Recruiting
Central vein sign in multiple sclerosis extension study
This study is for people already in the CAVS-MS study. It uses MRI scans to look at a specific sign in the brain that may help diagnose multiple sclerosis.
Los Angeles, CaliforniaAges 18–65 - NCT07299019RecruitingPhase 3
Study of orelabrutinib for secondary progressive MS
This study tests an oral medication called orelabrutinib for people whose multiple sclerosis has changed from relapsing-remitting to secondary progressive. The goal is to see if it can slow down disability worsening that happens even without relapses.
Phoenix, ArizonaAges 18–60 - NCT07225504RecruitingPhase 3
Study of remibrutinib for secondary progressive multiple sclerosis
This trial tests an oral medication called remibrutinib to see if it can slow disability progression in people with secondary progressive multiple sclerosis (SPMS). You might join if you have had MS for a while, your symptoms have worsened over the past year, and you haven't had any recent relapses.
Birmingham, AlabamaAges 18–65 - NCT07114809Recruiting
Can brain stimulation and virtual reality boost thinking in MS?
This study tests whether a combination of gentle brain stimulation (tDCS) and virtual reality exercises can improve memory and thinking problems in people with multiple sclerosis. If you have mild to moderate disability and no major health issues, you may be able to join.
Genova, ItalyAges 18–65 - NCT05258396Recruiting
Remyelination study for teens with multiple sclerosis
This study tests whether the brain may “repair” itself (re-myelinate) in children and teens with multiple sclerosis. It uses brain MRI to look for changes and may help clinicians better understand how to treat MS in younger people.
Le Kremlin-BicêtreAges 12–18 - NCT07564921Enrolling by invitation
Nutrition and Muscle Strength in Multiple Sclerosis With Swallowing Difficulty
This study looks at how nutritional status and muscle function relate to each other in people with multiple sclerosis who have difficulty swallowing. Understanding this connection may help doctors better support patients with MS who struggle with eating and drinking.
Gaziantep, şehitkamilAges 18–65 - NCT07380295Recruiting
Helping people with MS stay at work and feel better
This study tests a program to help people with multiple sclerosis (MS) stay active at work and improve their well-being. It is for adults aged 18 to 65 who have been referred for a neuropsychological assessment at Gävle Hospital.
GävleAges 18–65 - NCT06591429Recruiting
A study on hidden inflammation in multiple sclerosis
This study uses brain scans to look for hidden inflammation in people with multiple sclerosis who have not yet started a strong treatment. It aims to understand how this inflammation affects the disease and to help guide future therapies.
St Louis, MissouriAges 18 years+ - NCT07788859Recruiting
Testing dual-task walking tests in multiple sclerosis
This study looks at how well three different dual-task tests (doing two things at once while walking) work for people with multiple sclerosis. It aims to find reliable and valid ways to assess walking and thinking in MS.
GaziantepAges 18–65 - NCT06541626Recruiting
Study of CNS inflammatory demyelinating diseases
This study follows people with certain inflammatory conditions of the brain and spinal cord (like MS, NMOSD, or MOGAD) to learn more about their disease. If you join, you will help researchers understand these conditions better.
Guangzhou, GuangdongAges 18–65
Hear when a new Multiple Sclerosis (MS) - Relapsing-remitting trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.
Common questions
- Are there clinical trials for multiple sclerosis (ms) - relapsing-remitting?
- Yes. Clin2 currently lists 233 recruiting multiple sclerosis (ms) - relapsing-remitting studies from the U.S. registry, each rewritten for real people, not researchers, so you can see what it’s testing and who it’s for.
- How do I know if I qualify for a multiple sclerosis (ms) - relapsing-remitting trial?
- Each study lists its eligibility criteria — rules about age, diagnosis, and prior treatments. On every Clin2 trial page we explain these in words written for real people and offer a short, optional pre-screen for a fit read. The study team makes the final decision.
- Does it cost anything to join a multiple sclerosis (ms) - relapsing-remitting trial?
- Using Clin2 is always free. Many trials cover the cost of the study treatment and related visits; some reimburse travel. The study team explains exactly what’s covered before you decide.
Related conditions
Clin2 helps you find and understand clinical trials and does not provide medical advice. Study data comes from ClinicalTrials.gov. Talk with your doctor about whether a specific trial is right for you.